Results of G004, a phase IIb actively controlled clinical trial with the TGF-b2 targeted compound AP 12009 for recurrent anaplastic astrocytoma

Hau, P. and Stockhammer, G. and Kunst, M. and Mahapatra, A. and Sastry, K. V. and Parfenov, V. E. and Leshinsky, V. G. and Jachimczak, P. and Bogdahn, U. and Schlingensiepen, K. (2006) Results of G004, a phase IIb actively controlled clinical trial with the TGF-b2 targeted compound AP 12009 for recurrent anaplastic astrocytoma. JOURNAL OF CLINICAL ONCOLOGY, 24 (18Supp). 74S. ISSN 0732-183X

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurologie
Depositing User: Petra Gürster
Date Deposited: 16 Feb 2021 08:30
Last Modified: 16 Feb 2021 08:30
URI: https://pred.uni-regensburg.de/id/eprint/34432

Actions (login required)

View Item View Item